There seems to be a bit of discussion about where we find one of those, today. Better yet, how did we get the first one?Competition for resources by self replicating RNA molecules.
There seems to be a bit of discussion about where we find one of those, today. Better yet, how did we get the first one?Competition for resources by self replicating RNA molecules.
There seems to be a bit of discussion about where we find one of those, today. Better yet, how did we get the first one?
Didn’t you take care of all the probability problems with string theory?kjkent1 said:This is your third post, and I'm still waiting for you to compute all the probabilities.
Certainly I do. You can start with the results from ev computer model, a peer reviewed and published model of random point mutations and natural selection which shows this mechanism of evolution is so profoundly slow when using realistic genome lengths and mutation rates that nothing can evolve by this mechanism. Then you can again consider the concept of natural selection which can only operate if there is a benefit or detriment to the creature. I have shown that natural selection can not evolve a gene from the beginning. I will repeat it again since so many evolutionarians are in denial about this issue.Taffer said:My apologies, I thought my question was clear. Do you have any compelling evidence which would falsify these hypotheses?
This thread is about mathematically modeling evolution by mutation and selection. If you believe there is and was selective pressure to do this, present a description for this so that you can evolve a gene from the beginning. Feel free not to discuss this topic if you believe that all genes formed during abiogenesis. However, you have acknowledged the first step in disproving the theory of evolution. The next step is understanding that there is no selective pressure that can evolve a gene from the beginning. The only thing that natural selection can do is select for a creature with a beneficial property and select against a creature with a detrimental property. The addition of bases to a sequence which is neither beneficial nor detrimental will not alter the frequency of occurrence of that sequence in the population. Without selection pressure, the theory of evolution is not mathematically possible as you so correctly have said.Kleinman said:Without a selection process, neither abiogenesis nor the theory of evolution are mathematically possible.Taffer said:You are correct that, without selection pressure, the theory of evolution is not mathematically possible. However, there is and was selective pressure, so that is not a problem. As for abiogenesis, since it does not deal with evolution of anything, it might or might not require selective pressure. You would have to choose one hypothesis for us to discuss, as I am not versed in abiogenesis. I deal only with evolution.
Taffer, that’s a lovely semantic dance you are doing here.hammegk said:Yeah, that is a question being discussed. What did you say those pressures are?Taffer said:Competition for resources by self replicating RNA molecules.
hammegk said:There seems to be a bit of discussion about where we find one of those, today. Better yet, how did we get the first one?Taffer said:I don't know, hamme, I do not deal with abiogenesis.
Unless you defend your current position, I'll take your statement here as an admission by you that I have, in fact, refuted substantially all of your claims of mathematical impossibility, concerning both evolution and abiogenesis.Didn’t you take care of all the probability problems with string theory?
Kleinman said:Didn’t you take care of all the probability problems with string theory?
Kleinman said:kjkent1 said:Unless you defend your current position, I'll take your statement here as an admission by you that I have, in fact, refuted substantially all of your claims of mathematical impossibility, concerning both evolution and abiogenesis.
I don't know what you mean by "little gator," but if it's a reference to chronological age, I'm probably older than you are.Little gator, I think your refutation of my claims using string theory should be embraced by evolutionarians far and wide. It has been the only response to my claim that natural selection can not evolve a gene from the beginning.
Did you compute that probability?Kleinman said:Little gator, I think your refutation of my claims using string theory should be embraced by evolutionarians far and wide. It has been the only response to my claim that natural selection can not evolve a gene from the beginning.kjkent1 said:I don't know what you mean by "little gator," but if it's a reference to chronological age, I'm probably older than you are.
No, but the publicly available empirical evidence suggests to me that you're between 50 and 60 years old.Did you compute that probability?
...I’m not talking about abiogenesis, I am talking about the evolution of a new gene from the beginning. The gene that codes for insulin...
The two-chain hormone is derived biosynthetically from the immediate precursor, proinsulin which consists of the B and A chains linked to a connecting peptide (C-peptide) by adjacent pairs basic residues in the following order: NH2-B chain.Arg.Arg.C-peptide. Lys.Arg.A chain-COOH(2 3, 93, 136). However,the initial translation product of the insulin mRNiAs preproinsulin, which contains an N-terminal signal peptide, or prepeptide, of 24 amino acids linked to proinsulin (21).
Although insulin at one time was thought to be a structurally unique hormone, the pioneering studies of Froesch and Humbeal nd their coworkers( 40,110, 111, 159) have shown that other insulin-like activities not suppressed by the addition of anti-insulin antibody are present in the sera of mammals. The successful isolation and amino acid sequence determination of these substances, which have been named IGF-I and II in man (110, 111), clearly demonstrated their structural relationship to proinsulin, particularly in the conservation of the disulfide bridges and the presence of a short connecting peptide segment that is usually not removed. In addition to the insulin-like growth factors, the ovarian peptide hormone, relaxin, has been placed in the insulin superfamily on the basis of its primary and secondary structural homology to insulin (61). The submaxillary nerve growth factor (NGF) may also be a homologue of insulin (38), but in this case the evidence is less compelling (147a).
In most species the insulin gene exists in a single copy, except rats (79) and mice (18) where 2 nonallelic insulins are produced by closely related genes that are over 90% homologous in nucleotide sequence in the rat (79) (estimated divergence time 25-35 million years). Evidence suggests that the genes for rat and mouse insulin I, which in addition to the absence of IVS-2 (Figure 1) exhibit other hallmarks of retroposition, probably have arisen by RNA-mediaded rna transposition,as a functional gene, of a cDNA copy of an incompletely processed upstream transcript of insulin gene II into the ancestral murine germ line (122).
As noted earlier, it is now clear that several insulin-like growth factors (also known as multiplication stimulating activity (MSA) or somatomedin) circulate in mammals (e.g. rat MSA and human IGFs I and II).
The gene for IGF I is located on human chromosome 12, which may be evolutionarily related to chromosome (14, 143). The recent demonstration
of a larger variant form of IGFI I in humans suggests the existence of an
additional gene for IGF II in man (162). Although the exact time of divergence
of these molecules from insulin cannot be predicted with accuracy, they differ
more in amino acid sequence (-45% homology) than do the vertebrate insulins
(e.g. hagfish vs human -60% homology) suggesting an earlier separation time (>0.5 billion years). The recent finding of IGF-like peptides in Bombyxm orii
(90) tentatively supports this conclusion, although it is unclear as yet whether insulin, as such, also exists in such invertebrates. Thus far the evidence on putative invertebrate or prokaryotic insulins is fragmentary (35, 36, 78a, 105,140).
The above findings, coupled with evidence that IGF-I production is under control of pituitary growth hormone and may, in fact, be largely responsible for mediating postnatal somatic growth in the organism (1, 17, 40), strongly suggest the evolution of a complex and well-integrated system for the regulation of growth and metabolism in which insulin-like peptides (insulin and somatomedins) play a central role and are regulated by both nutritional and neural influences
...It is tempting to speculate that protoinsulin in simpler organisms was a metabolic hormone whose actions led to increased uptake and utilization of foodstuffs and, perhaps as a direct consequence, stimulated growth. However, as organisms became more complex and food supplies more limited, these two activities - nutrition and growth - had to be uncoupled. To accomplish this the primitive "insulin" system becamed diversified in evolution into superfamilies of related proteins and receptors, with differing relative potencies for regulating fuel metabolism on the one hand, or growth on the other. This hypothesis is supported by studies of the relative growth-promoting vs metabolic activities of insulin and the IGF peptides (40, 47, 70, 71, 160).
Relaxin has no insulin-like activity and little is known of its cell surface receptors, at present. However, as discussed in more detail below, recent studies of its mode of biosynthesis via preprorelaxin (74, 153) and of its gene structure support its probable evolutionary divergence from an ancestral antecedent of insulin.
Because it doesn't know the difference.How does this relate to the original point, anyway? You asked for the selective pressures which would lead to the formation of the first novel genes. I proved an example of one. Why, then, did you switch to abiogenesis?
Probably never knew it. And based on his repetition of a similar error regarding hemoglobin probably isn't capable of learning it.Kleinman has evidently forgotten that the insulin gene does not exist in isolation:
See, this is why Kleinman bothers me. Let me ask him this: suppose that a patient of his had a condition that could only be treated by acknowledging some of this research. Would he use that treatment? Would he even know it exists, since he denies this stuff is real?I realise that most JREF forum readers will realise that similar cases can be made for the other genes/proteins he mentions, but it is worth pointing out that such evolutionary genetics is not simply a sterile theoretical field. Genuine scientific and medical breakthroughs have been made by comparative genomic studies that are based on the assumption that both coding and non-coding sections of the genome are subject to evolutionary change over millions of years.
Kleinman said:...I’m not talking about abiogenesis, I am talking about the evolution of a new gene from the beginning. The gene that codes for insulin...
Kleinman said:Dr Richard said:Annual review of Genetics: structure and evolution of the insulin gene
Apologies for the block quotations, and long post, but I am not sure that many viewers will have access to Annual Reviews going back to 1985...
Kleinman has evidently forgotten that the insulin gene does not exist in isolation:
AndThe two-chain hormone is derived biosynthetically from the immediate precursor, proinsulin which consists of the B and A chains linked to a connecting peptide (C-peptide) by adjacent pairs basic residues in the following order: NH2-B chain.Arg.Arg.C-peptide. Lys.Arg.A chain-COOH(2 3, 93, 136). However,the initial translation product of the insulin mRNiAs preproinsulin, which contains an N-terminal signal peptide, or prepeptide, of 24 amino acids linked to proinsulin (21).
Although insulin at one time was thought to be a structurally unique hormone, the pioneering studies of Froesch and Humbeal nd their coworkers( 40,110, 111, 159) have shown that other insulin-like activities not suppressed by the addition of anti-insulin antibody are present in the sera of mammals. The successful isolation and amino acid sequence determination of these substances, which have been named IGF-I and II in man (110, 111), clearly demonstrated their structural relationship to proinsulin, particularly in the conservation of the disulfide bridges and the presence of a short connecting peptide segment that is usually not removed. In addition to the insulin-like growth factors, the ovarian peptide hormone, relaxin, has been placed in the insulin superfamily on the basis of its primary and secondary structural homology to insulin (61). The submaxillary nerve growth factor (NGF) may also be a homologue of insulin (38), but in this case the evidence is less compelling (147a).
Dr Richard said:Insulin is therefore part of a signalling superfamily. This is is of course the case with most signalling/receptor pathways, which exhibit multiple crossovers and redundancies. As might be expected from evolution with natural selection, or perhaps from a sloppy/incompetent designer. This is further evidenced by the fact there is not just one insulin gene, in rodents at least...
And so on…In most species the insulin gene exists in a single copy, except rats (79) and mice (18) where 2 nonallelic insulins are produced by closely related genes that are over 90% homologous in nucleotide sequence in the rat (79) (estimated divergence time 25-35 million years). Evidence suggests that the genes for rat and mouse insulin I, which in addition to the absence of IVS-2 (Figure 1) exhibit other hallmarks of retroposition, probably have arisen by RNA-mediaded rna transposition,as a functional gene, of a cDNA copy of an incompletely processed upstream transcript of insulin gene II into the ancestral murine germ line (122).
There are two issues you have to account for in your story in order to make it mathematically and scientifically consistent. The first is how did the ancestral antecedent of insulin arise from the beginning and the second is how did this ancestral antecedent of insulin morph into the other related hormones. You have no selection process that will evolve any gene from the beginning including your so called ancestral antecedent of insulin. And any process of morphing this so called ancestral antecedent of insulin into other hormones must have selective benefit to those creatures as it is morphing step by step from one hormone to the next. Do you care to describe this selective process that morphs these hormones from one to another so that it can be included in Dr Schneider’s mathematical model and the process demonstrated. Otherwise, mutation and selection is nothing more than a slogan with no mathematical or scientific basis.Relaxin has no insulin-like activity and little is known of its cell surface receptors, at present. However, as discussed in more detail below, recent studies of its mode of biosynthesis via preprorelaxin (74, 153) and of its gene structure support its probable evolutionary divergence from an ancestral antecedent of insulin.
You can make similar cases for any genes you want and I will ask you how the ancestral gene formed from the beginning and how these genes transformed from one to another. I don’t consider a slogan as a scientific answer.Dr Richard said:I realise that most JREF forum readers will realise that similar cases can be made for the other genes/proteins he mentions, but it is worth pointing out that such evolutionary genetics is not simply a sterile theoretical field. Genuine scientific and medical breakthroughs have been made by comparative genomic studies that are based on the assumption that both coding and non-coding sections of the genome are subject to evolutionary change over millions of years.Schneibster said:See, this is why Kleinman bothers me. Let me ask him this: suppose that a patient of his had a condition that could only be treated by acknowledging some of this research. Would he use that treatment? Would he even know it exists, since he denies this stuff is real?
We can't have doctors who ignore science. It comes perilously close to ignoring their Hippocratic Oath.
What medical breakthroughs depend on millions of years? Is it not really years or decades of evolutionary change for any such breakthroughs you might cite?Genuine ... medical breakthroughs have been made by comparative genomic studies that are based on the assumption that both coding and non-coding sections of the genome are subject to evolutionary change over millions of years.
Dr Richard, welcome to this discussion. I particularly appreciate that you quote the portion of your link that feel address my argument.
You can start with the results from ev computer model, a peer reviewed and published model of random point mutations and natural selection which shows this mechanism of evolution is so profoundly slow when using realistic genome lengths and mutation rates that nothing can evolve by this mechanism.
At least Dr Richard quotes the portions of his link that he thinks makes a valid argument. Now RecoveringYuppy simply says read Scientific American. Let me bring this discussion back on topic.RecoveringYuppy said:We've found parts of our genome that we didn't know were active by comparing the rate of accumulation of change in the various regions of DNA. Look back through Scientific American over the past two years for an article about the subject.
Dr Richard said:Firstly, I need to clarify a point:
You asked for a demonstration of the evolution of insulin.
I provided evidence back to the precursor from which proto insulin and proto relaxin diverged; this would seem not to be sufficient.
Dr Richard said:Definition and acceptable base sequence please.
Dr Richard said:You did not answer my other questions, hence I feel we must stall on this point for now.
What medical breakthroughs depend on millions of years?